Polio Vaccine Market Brand and Global Region Market Size, Latest Key Factors, Share & Forecast 2027
Poliovirus vaccines are the vaccines used for the prevention of poliomyelitis disease. The market is observing vibrant growth on account of rising awareness amongst people about the deadly effect of the disease, growing number of vaccinations operations and rise in investments for the development of different types of polio vaccines.
Furthermore, to prevent the deadly disease of poliomyelitis, nations
around the globe, along with organizations such as World Health Organization
(WHO) and the United Nations Children’s Fund (UNICEF) have initiated the Global
Polio Eradication Initiative (GPEI), which is also anticipated to raise the
demand for polio vaccines market.
Access Full Report, here: https://www.researchnester.com/sample-request-1999
The global
polio vaccine market is anticipated to record robust CAGR over the
forecast period, i.e. 2019-2027. The market is segmented by product
type into inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine
(OPV). Among these segments, oral poliovirus vaccine (OPV) segment is
anticipated to hold largest market share, owing to lower price of OPV as compared
to IPV, which is raising the affordability of OPV, especially in lower and
middle income nations around the globe. The purchase of OPV as per total annual
dosage reached 1,720,098,395 numbers in 2017 from 11,489,000 numbers in 2013,
as per the statistics provided by World Health Organization (WHO).
·
Oral poliovirus vaccine (OPV) segment is anticipated to hold largest
market share.
·
Asia-Pacific is expected to have largest market share.
·
Concerns observed in few lower income nations for socio-cultural issues
and other factors may hamper growth.
Geographically, the global polio vaccine market is segmented by five
major regions into North America, Europe, Asia-Pacific, Latin America and
Middle East & Africa region, out of which, Asia-Pacific is expected to have
largest market share on the back of increasing population in the region,
growing consumption of polio vaccines and presence of lower and middle income
nations, who can afford subsidized poliovirus vaccines from WHO and the United
Nations Children’s Fund (UNICEF). The annual dosage of poliovirus vaccines in
South East Asia region was recorded the highest amongst all the regions with
1,099,141,085 numbers in 2017 from 100,000 numbers in 2014.
However, concerns observed in few lower income nations for socio-cultural
issues and other factors, such as spread rumors, political issues and others,
coupled with threats of vaccine contamination, which might pose a massive
threat to the human population, are estimated to act as a barrier to the growth
of the market during the forecast period.
This report also studies existing competitive scenario of some of the
key players of the global polio vaccine market, which includes profiling:
·
GlaxoSmithKline plc. (LON: GSK)
·
Sanofi Pasteur Limited (NSE: SANOFI)
·
Astellas Pharma Inc. (TYO: 4503)
·
Pfizer Inc. (NYSE: PFE)
·
Novartis AG (SWX: NOVN)
·
F. Hoffmann-La Roche Ltd (SWX: ROG)
·
Merck & Co., Inc. (NYSE: MRK)
·
Abbvie Inc. (NYSE: ABBV)
·
Bharat Biotech and Serum Institute of India Pvt. Ltd.
Get a PDF Sample for more detailed
market insights: https://www.researchnester.com/sample-request-1999
About Research Nester:
Research Nester is a leading service provider for strategic market
research and consulting. We aim to provide unbiased, unparalleled market
insights and industry analysis to help industries, conglomerates and executives
to take wise decisions for their future marketing strategy, expansion and
investment etc. We believe every business can expand to its new horizon,
provided a right guidance at a right time is available through strategic minds.
Our out of box thinking helps our clients to take wise decisions so as to avoid
future uncertainties.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
Comments
Post a Comment